14294-11-2

Basic information

• Product Name: 2-PYRIDYLTHIOUREA
• Synonyms: AKOS BBS-00007311;1-(2-PYRIDYL)-2-THIOUREA;1-PYRIDIN-2-YLTHIOUREA;2-PYRIDYLTHIOUREA;N-PYRIDIN-2-YLTHIOUREA;N-(2-Pyridyl)thiourea, 98%;Thiourea,N-2-pyridinyl-;N-2-Pyridinyl-Thiourea
• CAS NO: 14294-11-2
• Molecular Formula: C₆H₇N₃S
• Molecular Weight: 153.2
• EINECS: -0
• Product Categories: Pyridines
• Mol File: 14294-11-2.mol
• Article Data: 30

Chemical Properties

• Melting Point: 148-150°C
• Boiling Point: 298.7 °C at 760 mmHg
• Flash Point: 134.4 °C
• Appearance: /
• Density: 1.382 g/cm³
• Refractive Index: 1.651
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 12.00±0.70(Predicted)
• BRN: 117849
• CAS DataBase Reference: 2-PYRIDYLTHIOUREA(CAS DataBase Reference)
• NIST Chemistry Reference: 2-PYRIDYLTHIOUREA(14294-11-2)
• EPA Substance Registry System: 2-PYRIDYLTHIOUREA(14294-11-2)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• RIDADR: 2811
• HazardClass: 6.1
• PackingGroup: III
• Hazardous Substances Data: 14294-11-2(Hazardous Substances Data)

Usage

Description

2-PYRIDYLTHIOUREA is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its ability to form disubstituted thiazoles and 2-amino-5-(thioaryl)thiazoles, which exhibit potent biological activities.

Uses

Used in Pharmaceutical Industry:
2-PYRIDYLTHIOUREA is used as an intermediate for the synthesis of disubstituted thiazoles, which have potential applications as antibacterial and anti-inflammatory agents. This is due to their ability to condense with phenacyl bromide, thioureas, and thiosemicarbazones, resulting in compounds with significant therapeutic properties.
Additionally, 2-PYRIDYLTHIOUREA is used as a precursor in the synthesis of 2-amino-5-(thioaryl)thiazoles. These compounds have been identified as potent and selective inhibitors of Itk, a protein tyrosine kinase involved in various cellular processes. Inhibiting Itk has been shown to have potential therapeutic benefits in treating autoimmune diseases and certain cancers, making 2-PYRIDYLTHIOUREA an important compound in the development of novel therapeutic agents.

InChI:InChI=1/C6H7N3OS/c7-6(10)9-11-5-3-1-2-4-8-5/h1-4H,(H3,7,9,10)

Upstream product

• 52648-45-0 2-pyridylisothiocyanate 
• 504-29-0 2-aminopyridine 
• 1147550-11-5 ammonium thiocyanate 
• 886-60-2 1-(2'-pyridyl)-3-phenylthiourea 
• 103-72-0 phenyl isothiocyanate 
• 13037-46-2 pyridin-2-yl-dithiocarbamic acid methyl ester 
• 150-76-5 4-methoxy-phenol 
• 4921-86-2 N-benzoyl-N'-(2-pyridyl)thiourea 

Downstream Products

• 54670-80-3 N-(thiazol-2-yl)pyridin-2-amine 
• 3833-85-0 4-fluoro-2-(2-pyridin-2-ylamino-thiazol-4-yl)-phenol 
• 846-69-5 4-fluoro-2-(5-methyl-2-pyridin-2-ylamino-thiazol-4-yl)-phenol 
• 13575-41-2 [1,3]thiazolo[4,5-b]pyridin-2-amine 
• 1235313-72-0 N-(4-(1-(4-methoxybenzyl)-3-isobutyl-1H-pyrazol-4-yl)thiazol-2-yl)pyridin-2-amine 
• 1235313-73-1 N-(4-(1-(4-methoxybenzyl)-5-isobutyl-1H-pyrazol-4-yl)thiazol-2-yl)pyridin-2-amine 
• 315705-34-1 [4-(3,4-dimethoxyphenyl)-thiazol-2-yl]-pyridin-2-yl-amine 
• 1235325-16-2 pyridin-2-yl-(4,5,6,8-tetrahydro-3-thia-1,7,8-triaza-cyclopenta[e]azulen-2-yl)-amine 
• 92663-22-4 N-(4-phenyl-1,3-thiazol-2-yl)-2-pyridinamine 
• 339231-86-6 N-(4-(2-(pyridin-2-ylamino)thiazol-4-yl)phenyl)acetamide 
• 3374-88-7 N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine 

Related news

Preparation of ruthenium (III) ion-imprinted beads based on 2-PYRIDYLTHIOUREA (cas 14294-11-2) modified chitosan07/18/2019

Ru(III) ion-imprinted bio-adsorbent based on 2-pyridylthiourea modified chitosan (Ru-PTCS) had been manufactured, investigated and employed for selective extraction of Ru(III) ions from aqueous medium containing interfering metal ions that maybe coexist and compete with Ru(III) ions. Elemental a...detailed

Relevant articles and documents

-

-

SO2F2-Mediated N-Alkylation of Imino-Thiazolidinones

The N-alkylation of ambident and weakly nucleophilic imino-thiazolidinones has been developed via substitution with alkyl fluorosulfonates. These reactive electrophiles are obtained through the transformation of nontoxic, economic, and commercially availa

Synthesis and antitumor evaluation of 5-(benzo[: D] [1,3]dioxol-5-ylmethyl)-4-(tert -butyl)- N -arylthiazol-2-amines

A series of novel N-aryl-5-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(tert-butyl)thiazol-2-amines (C1-C31) were synthesized and evaluated for their antitumor activities against HeLa, A549 and MCF-7 cell lines. Some tested compounds showed potent growth inhibition properties with IC50 values generally below 5 μM against the three human cancer cells lines. Compound C27 showed potent activities against HeLa and A549 cell lines with IC50 values of 2.07 ± 0.88 μM and 3.52 ± 0.49 μM, respectively. Compound C7 (IC50 = 2.06 ± 0.09 μM) was the most active compound against A549 cell line, while compound C16 (IC50 = 2.55 ± 0.34 μM) showed the best inhibitory activity against the MCF-7 cell line. The preliminary mechanism of the inhibitory effect was investigated via further experiments, such as morphological analysis by dual AO/EB staining and Hoechst 33342 staining, and cell apoptosis and cycle assessment by FACS analysis. The results illustrated that compound C27 could induce apoptosis and cause both S-phase and G2/M-phase arrests in HeLa cell line. Therefore, compound C27 could be developed as a potential antitumor agent.